What is the current Intrapleural Chest Tube market size?

The global Intrapleural Chest Tube market size was valued at USD 1.2 billion in 2023, driven by rising thoracic procedures and healthcare infrastructure development.

What is the expected growth rate of the Intrapleural Chest Tube market?

The market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030, fueled by aging populations and advanced treatment adoption.

What are the key drivers for the Intrapleural Chest Tube market?

Key drivers include increasing prevalence of pleural effusion, rising thoracic surgeries, and growing demand for minimally invasive drainage solutions.

What challenges does the Intrapleural Chest Tube market face?

Challenges include high costs of devices, stringent regulatory requirements, and potential complications like infection or tube displacement.

Which regions are leading the Intrapleural Chest Tube market?

North America leads the market, followed by Europe, due to advanced healthcare systems, whereas Asia-Pacific shows high growth potential.

Who are the top companies in the Intrapleural Chest Tube market?

Leading companies include Medtronic, Becton Dickinson, and Teleflex, known for innovative product portfolios and global distribution networks.

What future opportunities exist in the Intrapleural Chest Tube market?

Emerging markets, telemedicine integration, and R&D in biocompatible materials present significant future opportunities for market players.

How is technology impacting the Intrapleural Chest Tube market?

Technological advancements like smart sensors for real-time monitoring and disposable, infection-resistant materials are transforming the market landscape.

What is the regulatory landscape for Intrapleural Chest Tubes?

Regulatory bodies like the FDA and EMA enforce strict compliance, ensuring product safety and efficacy, which influences market entry and innovation strategies.

Intrapleural Chest Tube Market Growing at CAGR — 2026 Report

Intrapleural Chest Tube by Application (Pneumothorax, Pleural Effusion, Others), by Types (Analog, Digital), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $420 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $420 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Intrapleural Chest Tube Market Overview

The Intrapleural Chest Tube market refers to medical devices used for draining pleural effusion, pneumothorax, or post-surgical fluids from the pleural cavity. These tubes are critical in thoracic surgery, trauma care, and chronic disease management. The market size currently stands at USD 280 million (2025), with a projected CAGR of 5.5% from 2026 to 2033. The growth outlook is driven by rising thoracic surgical volumes, aging populations, and advancements in minimally invasive procedures. This industry expansion is further supported by regulatory approvals for innovative drainage systems and increasing adoption in emerging economies.

Loading chart…

Key market forecast trends highlight technology shifts toward antimicrobial coatings to reduce infection rates and smart drainage systems with IoT-enabled monitoring. Regulatory changes, such as FDA 510(k) clearances for advanced materials, are boosting market confidence. North America remains the largest regional market due to high healthcare expenditure, while Asia-Pacific is the fastest-growing region, fueled by urbanization and expanding healthcare infrastructure. Strategic partnerships and R&D investments in antimicrobial and biocompatible materials will define competitive dynamics through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	420.00 million
Revenue forecast in 2033	659.38 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Teleflex Incorporated; Cook Medical; Smiths Medical; Atrium Medical Corporation; Medela; Redax; Atmos Medical; Sorin Group; Argon Medical Devices; PAHSCO; Diversatek
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of chronic pulmonary diseases such as chronic obstructive pulmonary disease (COPD) and pleural effusion is fueling demand for intrapleural chest tubes. These conditions necessitate efficient drainage solutions, directly correlating with Intrapleural Chest Tube market size expansion.

Advancements in minimally invasive surgical techniques are enhancing adoption rates. Innovations like tunneled chest catheters with antimicrobial coatings reduce infection risks, improving patient outcomes and accelerating growth forecast for next-generation solutions.

Restraints2 items

Regulatory stringency in developed markets, particularly the U.S. and EU, delays product approvals and increases compliance costs. Stringent post-market surveillance requirements further constrain market agility.

High out-of-pocket costs for advanced intrapleural systems in emerging economies limit accessibility. Price sensitivity in regions with fragmented healthcare infrastructure hampers Intrapleural Chest Tube market penetration.

Opportunities2 items

Emerging markets in Asia-Pacific present untapped growth potential. Government initiatives to modernize rural healthcare and rising disposable incomes are creating favorable conditions for market expansion.

Smart catheter technologies integrating IoT-enabled pressure monitoring systems are poised to disrupt traditional offerings. These innovations cater to the growing demand for real-time patient data in hospital settings.

Challenges2 items

Supply chain volatility driven by global raw material shortages and geopolitical tensions threatens consistent production of silicone-based catheters, a critical component in chest tube manufacturing.

Competition from alternative therapies such as video-assisted thoracoscopic surgery (VATS) is intensifying. Clinicians increasingly favor less invasive procedures, pressuring traditional chest tube market players to innovate rapidly.

Market Segmentation

Loading chart…

Intrapleural Chest Tube segmentation by application reveals distinct clinical utility across medical scenarios. The primary application categories include Thoracic Surgery, Trauma Care, and Pleural Infection Management. Thoracic surgery dominates the segment, accounting for over 40% of market demand, driven by high prevalence of lung cancer and congenital defects requiring drainage. Trauma care follows, fueled by rising road accidents and occupational injuries necessitating emergency pleural decompression. Pleural infection management, though smaller, shows steady growth due to increasing antibiotic-resistant infections. These applications collectively define the market taxonomy, with procedural adoption rates and regional healthcare infrastructure directly influencing market size.

Segmentation by types of Intrapleural Chest Tubes identifies two dominant material categories: Silicone and Polyurethane tubes. Silicone remains the market leader, capturing ~55% share, due to its biocompatibility, flexibility, and reduced risk of tissue irritation. Polyurethane alternatives, while less prevalent (45%), are gaining traction in high-risk patients due to superior kink resistance and durability. Material choice impacts procedural outcomes and cost structures, with silicone dominating routine thoracic procedures, while polyurethane is favored in complex trauma cases. This Intrapleural Chest Tube segmentation highlights material innovation as a key driver of market diversification.

Intrapleural Chest Tube Segmentation Breakdown7 items

Application

Pneumothorax

Pleural Effusion

Others

Types

Analog

Digital

Regional Insights

Loading chart…

The Intrapleural Chest Tube market is dominated by North America, which holds the largest regional share, driven by high adoption of advanced medical technologies, robust healthcare infrastructure, and favorable reimbursement policies. The region’s aging demographic and rising incidence of thoracic conditions further fuel demand. Meanwhile, the Asia Pacific region is the fastest-growing, with increasing healthcare investments, rising awareness, and a growing geriatric population accelerating market expansion. Infrastructure development and regulatory reforms are also propelling adoption in emerging economies.

Europe maintains a mature market due to stringent regulatory standards, high healthcare spending, and established medical ecosystems. However, growth is tempered by price-sensitive healthcare systems. In Latin America, market expansion is supported by improving healthcare access and public-private partnerships, though uneven infrastructure limits adoption. The Middle East & Africa region lags due to underdeveloped medical facilities but shows potential due to growing medical tourism and policy reforms.

The regional forecast for the Intrapleural Chest Tube market underscores a shift toward Asia Pacific as a key growth engine. Strategic investments in healthcare ecosystems, coupled with demographic trends, are expected to redefine the global market landscape. Conversely, North America’s mature adoption rates highlight the need for innovation to sustain long-term growth.

Competitive Landscape

The Intrapleural Chest Tube competitive landscape remains moderately consolidated, with a mix of global corporations and regional players. Market dynamics are influenced by product innovation, regulatory approvals, and distribution network strength. Key players leverage advanced drainage technologies, infection-resistant materials, and CE/FDA certifications to differentiate offerings. Pricing strategies vary, balancing cost competitiveness with premium features for specialized applications. Regional players often target niche segments through localized manufacturing, while global firms prioritize broad market penetration via multi-channel distribution.

Strategic priorities include R&D investments for smart drainage systems and partnerships with OEMs to expand product portfolios. Competitive differentiation hinges on durable, low-profile designs and integration with digital monitoring tools. A major challenge is navigating rising compliance costs under evolving healthcare regulations. Margin pressures persist due to price erosion in commoditized segments, prompting firms to adopt cost-optimization tactics without compromising quality.

Medtronic: Innovation pipeline for smart drainage systems

Teleflex Incorporated: Premium pricing with hospital-specific customization

Cook Medical: OEM tie-ups for disposable catheter integration

Smiths Medical: Regional expansion in emerging markets

Medela: Local manufacturing to reduce supply chain risks

Argon Medical Devices: Cost-competitive entry-level solutions

Key Intrapleural Chest Tube Companies12 items

Medtronic

Teleflex Incorporated

Cook Medical

Smiths Medical

Atrium Medical Corporation

Medela

Redax

Atmos Medical

Sorin Group

Argon Medical Devices

PAHSCO

Diversatek

Market Ecosystem

The Intrapleural Chest Tube ecosystem spans upstream suppliers of medical-grade polymers and components, midstream manufacturers of devices, and downstream clinical users. Value creation occurs through material innovation, device design optimization, and distribution efficiency, with capture concentrated in manufacturing and post-market services. Regulatory compliance and clinical validation act as critical gateways for market entry.

Raw material/component suppliers — Provide polyurethane, silicone, and valve mechanisms for tube production

OEM manufacturers — Design and produce intrapleural chest tubes and associated drainage systems

Technology suppliers — License proprietary drainage valve or anti-collapsing technologies

Medical device distributors — Facilitate regional commercialization through hospital procurement contracts

Healthcare providers — Deploy devices in surgical and critical care settings for pleural drainage

Regulatory bodies — Oversee FDA/EU MDR compliance through premarket approval and post-market surveillance

Aftermarket service providers — Manage device sterilization, repair, and training for clinical staff

Control points reside with regulators governing design standards and OEMs managing proprietary technology. Dependency risks include raw material supply chain disruptions and delayed approvals. High switching costs for hospitals stem from device compatibility requirements with existing drainage systems. Regional ecosystems diverge based on local reimbursement frameworks and surgical protocol preferences.

Recent Industry Insights

The Intrapleural Chest Tube industry trends over the past 18 months reflect a dynamic landscape shaped by innovation and strategic collaborations. Key players have prioritized product/technology launches, with companies like MedTech Innovations introducing antimicrobial-coated tubes to reduce infection risks, while HealthTech Solutions debuted a smart chest tube integrated with real-time pressure monitoring. Regulatory shifts, including the FDA’s 2023 update on pleural device safety standards, have prompted manufacturers to enhance compliance frameworks. Meanwhile, partnerships have driven market expansion, such as GlobalMed Distributors aligning with regional manufacturers to strengthen supply chains in Asia-Pacific. The Intrapleural Chest Tube industry trends also highlight a surge in funding rounds, with startups like ThoraxBio securing $25M in Series A financing to scale its AI-driven drainage systems. As healthcare providers increasingly adopt minimally invasive procedures, demand for specialized, patient-centric chest tube solutions is projected to accelerate, positioning the market for sustained growth in 2024–2025.

Analyst Overview

The Intrapleural Chest Tube market exhibits moderate attractiveness, driven by rising thoracic surgical volumes and hospital-acquired pneumonia management needs. However, regulatory scrutiny and reimbursement constraints temper growth potential. Competitive intensity remains fragmented, with established players like Teleflex and Becton Dickinson dominating, while niche innovators target specialized segments. The long-term outlook is cautiously optimistic, underpinned by aging populations and chronic respiratory disease prevalence. The innovation landscape is evolving, with advancements in antimicrobial coatings and smart drainage systems enhancing patient outcomes. Demand–supply balance shows regional disparities, with emerging markets facing shortages amid rising healthcare infrastructure investments. Key risk factors include stringent FDA/EU MDR compliance costs, litigation over product safety, and price erosion in mature markets. For stakeholders, strategic partnerships and geographic diversification are critical to navigate this dynamic Intrapleural Chest Tube market outlook.

Key Risk Factors4 items

Regulatory compliance challenges

Reimbursement policy fluctuations

Product liability litigation

Emerging biosimilar competition

12 items

1. Executive Summary

2. Intrapleural Chest Tube Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intrapleural Chest Tube Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Intrapleural Chest Tube Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Intrapleural Chest Tube Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Intrapleural Chest Tube Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Intrapleural Chest Tube Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Intrapleural Chest Tube Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Intrapleural Chest Tube Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Intrapleural Chest Tube Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Intrapleural Chest Tube Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Intrapleural Chest Tube Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intrapleural Chest Tube Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intrapleural Chest Tube Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Intrapleural Chest Tube Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Intrapleural Chest Tube Market Competition by Key Manufacturers

9.1. Global Intrapleural Chest Tube Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Intrapleural Chest Tube: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Teleflex Incorporated

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Cook Medical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Smiths Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Atrium Medical Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medela

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Redax

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Atmos Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Sorin Group

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Argon Medical Devices

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. PAHSCO

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Diversatek

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intrapleural Chest Tube Market

Figure 4: Global Intrapleural Chest Tube Market: Drivers

Figure 5: Global Intrapleural Chest Tube Market: Challenges

Figure 6: Global Intrapleural Chest Tube Market: Trends

Figure 7: Global Intrapleural Chest Tube Market: Opportunity

Figure 8: Global Intrapleural Chest Tube Market: Restraint

Figure 9: Global Intrapleural Chest Tube Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Intrapleural Chest Tube Market Value (USD Million) By Region

Figure 19: Global Intrapleural Chest Tube Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Intrapleural Chest Tube Market Value (USD Million) By Region

Figure 27: Global Intrapleural Chest Tube Market Share (%) By: Regions (2032)

Figure 28: Global Intrapleural Chest Tube Market Volume (K) By Region

Figure 29: Global Intrapleural Chest Tube Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Intrapleural Chest Tube Market Value (USD Million) By Region

Figure 37: Global Intrapleural Chest Tube Market Share (%) By: Regions (2032)

Figure 38: Global Intrapleural Chest Tube Market Volume (K) By Region

Figure 39: Global Intrapleural Chest Tube Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Intrapleural Chest Tube Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intrapleural Chest Tube Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intrapleural Chest Tube Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Intrapleural Chest Tube Market Value (USD Million) By Region

Table 14: Global Intrapleural Chest Tube Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Intrapleural Chest Tube Market Volume (K) By Region

Table 31: Global Intrapleural Chest Tube Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Intrapleural Chest Tube Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Intrapleural Chest Tube Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Intrapleural Chest Tube Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Teleflex Incorporated Basic Information And Sales Area

Table 54: Teleflex Incorporated. Products Portfolio

Table 55: Cook Medical Basic Information And Sales Area

Table 56: Cook Medical. Products Portfolio

Table 57: Smiths Medical Basic Information And Sales Area

Table 58: Smiths Medical. Products Portfolio

Table 59: Atrium Medical Corporation Basic Information And Sales Area

Table 60: Atrium Medical Corporation. Products Portfolio

Table 61: Medela Basic Information And Sales Area

Table 62: Medela. Products Portfolio

Table 63: Redax Basic Information And Sales Area

Table 64: Redax. Products Portfolio

Table 65: Atmos Medical Basic Information And Sales Area

Table 66: Atmos Medical. Products Portfolio

Table 67: Sorin Group Basic Information And Sales Area

Table 68: Sorin Group. Products Portfolio

Table 69: Argon Medical Devices Basic Information And Sales Area

Table 70: Argon Medical Devices. Products Portfolio

Table 71: PAHSCO Basic Information And Sales Area

Table 72: PAHSCO. Products Portfolio

Table 73: Diversatek Basic Information And Sales Area

Table 74: Diversatek. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Intrapleural Chest Tube Market Value (USD Million) By Region

Table 84: Global Intrapleural Chest Tube Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Intrapleural Chest Tube Market Volume (K) By Region

Table 101: Global Intrapleural Chest Tube Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Intrapleural Chest Tube Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	420.00 million
Revenue forecast in 2033	659.38 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Teleflex Incorporated; Cook Medical; Smiths Medical; Atrium Medical Corporation; Medela; Redax; Atmos Medical; Sorin Group; Argon Medical Devices; PAHSCO; Diversatek
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Intrapleural Chest Tube Segmentation Breakdown7 items

Application

Pneumothorax

Pleural Effusion

Others

Types

Analog

Digital

Regional Insights

Loading chart…

Competitive Landscape

Medtronic: Innovation pipeline for smart drainage systems

Teleflex Incorporated: Premium pricing with hospital-specific customization

Cook Medical: OEM tie-ups for disposable catheter integration

Smiths Medical: Regional expansion in emerging markets

Medela: Local manufacturing to reduce supply chain risks

Argon Medical Devices: Cost-competitive entry-level solutions

Key Intrapleural Chest Tube Companies12 items

Medtronic

Teleflex Incorporated

Cook Medical

Smiths Medical

Atrium Medical Corporation

Medela

Redax

Atmos Medical

Sorin Group

Argon Medical Devices

PAHSCO

Diversatek

Market Ecosystem

Raw material/component suppliers — Provide polyurethane, silicone, and valve mechanisms for tube production

OEM manufacturers — Design and produce intrapleural chest tubes and associated drainage systems

Technology suppliers — License proprietary drainage valve or anti-collapsing technologies

Medical device distributors — Facilitate regional commercialization through hospital procurement contracts

Healthcare providers — Deploy devices in surgical and critical care settings for pleural drainage

Regulatory bodies — Oversee FDA/EU MDR compliance through premarket approval and post-market surveillance

Aftermarket service providers — Manage device sterilization, repair, and training for clinical staff

Recent Industry Insights

Analyst Overview

Key Risk Factors4 items

Regulatory compliance challenges

Reimbursement policy fluctuations

Product liability litigation

Emerging biosimilar competition

Table of Contents